Literature DB >> 2505056

Secretory expression in Escherichia coli and Bacillus subtilis of human interferon alpha genes directed by staphylokinase signals.

R Breitling1, D Gerlach, M Hartmann, D Behnke.   

Abstract

A DNA segment covering the signal sequence coding region, the ribosome binding site, and the promoter of the staphylokinase (sak) 42D gene (Behnke and Gerlach 1987) was cloned into pUC19 to form a portable expression-secretion unit (ESU). Fusion of human interferon alpha 1 (hIFN alpha 1) and hybrid hIFN alpha 1/2 genes to this sak ESU resulted in secretory expression of the two gene products in both Escherichia coli and Bacillus subtilis. While most of the IFN alpha was exported to the periplasmic space of E. coli, about 99% was secreted to the culture medium by recombinant B. subtilis strains. The total yield in E. coli was 1.2 x 10(5) IU/ml. This level of expression and export led to instability of the recombinant strains that was spontaneously relieved in vivo by inactivation of the sak ESU through insertion of an IS1 element. No such instability was observed with B. subtilis although expression and secretion levels reached even 3 x 10(6) IU/ml. Proteolytic degradation of IFN alpha by extracellular proteases was avoided by a combination of constitutive expression and secretion during the logarithmic growth phase and the use of exoprotease-reduced host strains. The IFN alpha 1 protein purified from B. subtilis culture supernatant was correctly processed, carried the expected 11 amino acid N-terminal elongation that resulted from DNA manipulations and proved to be homogenous in Western blotting experiments. The same recombinant plasmid that directed efficient secretion of hIFN alpha 1 in B. subtilis gave poor yields when introduced into Streptococcus sanguis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505056     DOI: 10.1007/bf02464908

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  37 in total

1.  Escherichia coli integration host factor binds specifically to the ends of the insertion sequence IS1 and to its major insertion hot-spot in pBR322.

Authors:  P Gamas; M G Chandler; P Prentki; D J Galas
Journal:  J Mol Biol       Date:  1987-05-20       Impact factor: 5.469

2.  Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells.

Authors:  M Dagert; S D Ehrlich
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

3.  Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis.

Authors:  D Gerlach; R Kraft; D Behnke
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-11

4.  Location of antibiotic resistance determinants, copy control, and replication functions on the double-selective streptococcal cloning vector pGB301.

Authors:  D Behnke; M S Gilmore
Journal:  Mol Gen Genet       Date:  1981

5.  Secretion of Bacillus subtilis alpha-amylase in the periplasmic space of Escherichia coli.

Authors:  K Tachibana; K Yoda; S Watanabe; H Kadokura; Y Katayama; K Yamane; M Yamasaki; G Tamura
Journal:  J Gen Microbiol       Date:  1987-07

6.  Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteases.

Authors:  F Kawamura; R H Doi
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

7.  Synthesis and secretion of human epidermal growth factor by Escherichia coli.

Authors:  T Oka; S Sakamoto; K Miyoshi; T Fuwa; K Yoda; M Yamasaki; G Tamura; T Miyake
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Bacillus subtilis requires a "stringent" Shine-Dalgarno region for gene expression.

Authors:  L Band; D J Henner
Journal:  DNA       Date:  1984

9.  Transcription and translation of foreign genes in Bacillus subtilis by the aid of a secretion vector.

Authors:  I Ulmanen; K Lundström; P Lehtovaara; M Sarvas; M Ruohonen; I Palva
Journal:  J Bacteriol       Date:  1985-04       Impact factor: 3.490

10.  Cloning and expression in Escherichia coli, Bacillus subtilis, and Streptococcus sanguis of a gene for staphylokinase--a bacterial plasminogen activator.

Authors:  D Behnke; D Gerlach
Journal:  Mol Gen Genet       Date:  1987-12
View more
  9 in total

1.  Transcriptional start sites of the staphylokinase 42D promoter in E. coli and B. subtilis.

Authors:  T Ellinger; D Behnke
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

2.  Dot blot hybridization using cytoplasmic extracts is inappropriate for determination of mRNA levels in regenerating liver.

Authors:  A Tsykin; T Thomas; J Milland; A R Aldred; G Schreiber
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

Review 3.  Protein secretion in Bacillus species.

Authors:  M Simonen; I Palva
Journal:  Microbiol Rev       Date:  1993-03

4.  Influence of stringent and relaxed response on excretion of recombinant proteins and fatty acid composition in Escherichia coli.

Authors:  B Gitter; R Diefenbach; H Keweloh; D Riesenberg
Journal:  Appl Microbiol Biotechnol       Date:  1995-04       Impact factor: 4.813

5.  Improvement of recombinant gene expression in Escherichia coli for glucose-controlled continuous and fed-batch cultures.

Authors:  V Schroeckh; M Hartmann; E Birch-Hirschfeld; D Riesenberg
Journal:  Appl Microbiol Biotechnol       Date:  1992-01       Impact factor: 4.813

6.  High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1.

Authors:  D Riesenberg; K Menzel; V Schulz; K Schumann; G Veith; G Zuber; W A Knorre
Journal:  Appl Microbiol Biotechnol       Date:  1990-10       Impact factor: 4.813

7.  Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains.

Authors:  Antonia Lakowitz; Rainer Krull; Rebekka Biedendieck
Journal:  Microb Cell Fact       Date:  2017-01-23       Impact factor: 5.328

8.  Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b.

Authors:  Iram Gull; Zahoor Qadir Samra; Muhammad Shahbaz Aslam; Muhammad Amin Athar
Journal:  Springerplus       Date:  2013-06-15

9.  Enabling low cost biopharmaceuticals: high level interferon alpha-2b production in Trichoderma reesei.

Authors:  Christopher P Landowski; Eero Mustalahti; Ramon Wahl; Laurence Croute; Dhinakaran Sivasiddarthan; Ann Westerholm-Parvinen; Benjamin Sommer; Christian Ostermeier; Bernhard Helk; Juhani Saarinen; Markku Saloheimo
Journal:  Microb Cell Fact       Date:  2016-06-10       Impact factor: 5.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.